Source: Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ris (Lausanne, Switzerland). The management of single metastasis in stage M1b. Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?

Member's Comments

No comment yet.

Related content which might interest you: Is the highest mediastinal lymph node a prognostic factor in stage IIIA N2 NSCLC? Source: ISSN=ISSN 1810-6838, ISBN=, page=355 Year: 2006 Central tumor location and presence of occult lymph node metastasis in cT1N0M0 NSCLC Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment Source: Eur Respir J 2009; 33: 1383-1388 Year: 2009 Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019 Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer Source: Eur Respir J 2013; 41: 649-655 Year: 2013 Risk factors for occult mediastinal lymph node involvement in clinical stage I lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=163 Year: 2007 N3 hilar sampling decision in the staging of mediastinal lung cancer Source: ERJ Open Res, 7 (3) 00116-2021; 10.1183/23120541.00116-2021 Year: 2021 The efficacy of induction chemoradiotherapy followed by surgery in stage IIIA-proven N2 NSCLC and the influence of lymph node downstage on the incidence of postoperative recurrence Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006 Distant metastases of lung cancer at the time of diagnosis Source: Eur Respir J 2006; 28: Suppl. 50, 74s Year: 2006 Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 The role of PET-CT in mediastinal lymph node staging in NSCLC Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007